FDA Forbade Fosamax Warnings, Merck Tells 3rd Circ.
Merck told the Third Circuit on Monday that the U.S. Food and Drug Administration prohibited it from warning patients about the risk of its osteoporosis drug Fosamax causing irregular hip fractures,...To view the full article, register now.
Already a subscriber? Click here to view full article